These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 29311261)

  • 1. Towards stem cell based therapies for Parkinson's disease.
    Parmar M
    Development; 2018 Jan; 145(1):. PubMed ID: 29311261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell therapy for Parkinson's disease: Functional role of the host immune response on survival and differentiation of dopaminergic neuroblasts.
    Wenker SD; Leal MC; Farías MI; Zeng X; Pitossi FJ
    Brain Res; 2016 May; 1638(Pt A):15-29. PubMed ID: 26239914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated astrocytes enhance the dopaminergic differentiation of stem cells and promote brain repair through bFGF.
    Yang F; Liu Y; Tu J; Wan J; Zhang J; Wu B; Chen S; Zhou J; Mu Y; Wang L
    Nat Commun; 2014 Dec; 5():5627. PubMed ID: 25517983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease.
    Chen LW; Kuang F; Wei LC; Ding YX; Yung KK; Chan YS
    CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):449-58. PubMed ID: 21495962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional Rescue of Dopaminergic Neuron Loss in Parkinson's Disease Mice After Transplantation of Hematopoietic Stem and Progenitor Cells.
    Altarche-Xifro W; di Vicino U; Muñoz-Martin MI; Bortolozzi A; Bové J; Vila M; Cosma MP
    EBioMedicine; 2016 Jun; 8():83-95. PubMed ID: 27428421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease.
    Chen W; Huang Q; Ma S; Li M
    ACS Chem Neurosci; 2019 Feb; 10(2):839-851. PubMed ID: 30346716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human induced pluripotent stem cell-derived neurons improve motor asymmetry in a 6-hydroxydopamine-induced rat model of Parkinson's disease.
    Han F; Wang W; Chen B; Chen C; Li S; Lu X; Duan J; Zhang Y; Zhang YA; Guo W; Li G
    Cytotherapy; 2015 May; 17(5):665-79. PubMed ID: 25747741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin C-Induced Epigenetic Modifications in Donor NSCs Establish Midbrain Marker Expressions Critical for Cell-Based Therapy in Parkinson's Disease.
    Wulansari N; Kim EH; Sulistio YA; Rhee YH; Song JJ; Lee SH
    Stem Cell Reports; 2017 Oct; 9(4):1192-1206. PubMed ID: 28943252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of stem cells in regenerative medicine for Parkinson's and Huntington's Diseases.
    Lescaudron L; Naveilhan P; Neveu I
    Curr Med Chem; 2012; 19(35):6018-35. PubMed ID: 22963567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem Cells for Modeling and Therapy of Parkinson's Disease.
    Zhang Q; Chen W; Tan S; Lin T
    Hum Gene Ther; 2017 Jan; 28(1):85-98. PubMed ID: 27762639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding Parkinson's Disease through the Use of Cell Reprogramming.
    Playne R; Connor B
    Stem Cell Rev Rep; 2017 Apr; 13(2):151-169. PubMed ID: 28083784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The future of cell therapies and brain repair: Parkinson's disease leads the way.
    Petit GH; Olsson TT; Brundin P
    Neuropathol Appl Neurobiol; 2014 Feb; 40(1):60-70. PubMed ID: 24372386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human olfactory stem cells: As a promising source of dopaminergic neuron-like cells for treatment of Parkinson's disease.
    Alizadeh R; Kamrava SK; Bagher Z; Farhadi M; Falah M; Moradi F; Boroujeni ME; Soleimani M; Kamyab A; Komeili A
    Neurosci Lett; 2019 Mar; 696():52-59. PubMed ID: 30552942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine release from transplanted neural stem cells in Parkinsonian rat striatum in vivo.
    Kang X; Xu H; Teng S; Zhang X; Deng Z; Zhou L; Zuo P; Liu B; Liu B; Wu Q; Wang L; Hu M; Dou H; Liu W; Zhu F; Li Q; Guo S; Gu J; Lei Q; Lü J; Mu Y; Jin M; Wang S; Jiang W; Liu K; Wang C; Li W; Zhang K; Zhou Z
    Proc Natl Acad Sci U S A; 2014 Nov; 111(44):15804-9. PubMed ID: 25331880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson's disease.
    Hallett PJ; Deleidi M; Astradsson A; Smith GA; Cooper O; Osborn TM; Sundberg M; Moore MA; Perez-Torres E; Brownell AL; Schumacher JM; Spealman RD; Isacson O
    Cell Stem Cell; 2015 Mar; 16(3):269-74. PubMed ID: 25732245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoring Function to Dopaminergic Neurons: Progress in the Development of Cell-Based Therapies for Parkinson's Disease.
    Henchcliffe C; Sarva H
    CNS Drugs; 2020 Jun; 34(6):559-577. PubMed ID: 32472450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Parkinson's disease using cell transplantation.
    Lindvall O
    Philos Trans R Soc Lond B Biol Sci; 2015 Oct; 370(1680):20140370. PubMed ID: 26416681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretome of Undifferentiated Neural Progenitor Cells Induces Histological and Motor Improvements in a Rat Model of Parkinson's Disease.
    Mendes-Pinheiro B; Teixeira FG; Anjo SI; Manadas B; Behie LA; Salgado AJ
    Stem Cells Transl Med; 2018 Nov; 7(11):829-838. PubMed ID: 30238668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell Therapy for Parkinson's Disease.
    Yasuhara T; Kameda M; Sasaki T; Tajiri N; Date I
    Cell Transplant; 2017 Sep; 26(9):1551-1559. PubMed ID: 29113472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replacing Dopamine Neurons in Parkinson's Disease: How did it happen?
    Björklund A; Lindvall O
    J Parkinsons Dis; 2017; 7(s1):S21-S31. PubMed ID: 28282811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.